chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Got the shot before getting shingles/Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than a year after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got the shot before getting shingles/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles).The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 08-MAR-2023 This case was reported by a patient via interactive digital media. The patient got the shingles shot about one year before getting shingles.  The reporter stated that it was true story. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory test confirming shingles were unknown at the time of reporting. The follow up would not possible as no contact details were available.
Fever 105 26 hrs p/DTP given; fever controlled w/APAP;
Having heart issues; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received bnt162b2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection and Lot number: Not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced having heart issues on an unspecified date. The outcome of the event was unknown.  No follow-up attempts are possible. Information about batch number cannot be obtained.
congestion feeling in the nasal passages but not actually congested; face numbness around nose and upper lip; around nose and upper lip which is kind of allergy but no sneezing or no coughing(; arm hurt little bit; Fever temperature 102 degrees; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (congestion feeling in the nasal passages but not actually congested), HYPOAESTHESIA (face numbness around nose and upper lip), ALLERGY TO VACCINE (around nose and upper lip which is kind of allergy but no sneezing or no coughing(), PAIN IN EXTREMITY (arm hurt little bit) and PYREXIA (Fever temperature 102 degrees) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 035C21A and 039821A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in April 2020.   On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-May-2021, the patient experienced PAIN IN EXTREMITY (arm hurt little bit) and PYREXIA (Fever temperature 102 degrees). On 27-May-2021, the patient experienced NASAL CONGESTION (congestion feeling in the nasal passages but not actually congested), HYPOAESTHESIA (face numbness around nose and upper lip) and ALLERGY TO VACCINE (around nose and upper lip which is kind of allergy but no sneezing or no coughing(). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 27-May-2021, PAIN IN EXTREMITY (arm hurt little bit) outcome was unknown, PYREXIA (Fever temperature 102 degrees) had resolved. At the time of the report, NASAL CONGESTION (congestion feeling in the nasal passages but not actually congested), HYPOAESTHESIA (face numbness around nose and upper lip) and ALLERGY TO VACCINE (around nose and upper lip which is kind of allergy but no sneezing or no coughing() outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-May-2021, Body temperature: high degree Celsius (High) Fever temperature 102 degrees.         No concomitant medications were reported.   This case was linked to MOD-2021-187071 (Patient Link).
2 days p/vax pt devel marked swelling of the hands & feet & urticaria on hands, arms, & face;pt seen in ER where a dx of erythema multiforme was made;tx w/DPH & pred & was recovered @ the date of this report;
7cm x 9 1/2 cm area of erythema (R) upper arm; No pus or pain.
Patient reports she experienced a headache and exhaustion starting 30 hours after the vaccine.  She reports the side effects resolved by 3/19.
Pt received his Flu shot and shortly after he went home he started to swell up and throat closed. He went to the ER for tx. Received steroids etc. and was released. Pt had a F/u with his PCP and called us to report.
Dad states got sick about 1mo p/vax;child c/o h/a, stomachache, chest pain & went to ER;told from ER APAP for h/a thought child has gastric upset & made child hyperventilate which cause chest pain;still having h/a;
Patient is hospitalized with COVID and is receiving treatment with 8L high flow nasal cannula oxygen and dexamethasone
temp 102.2 ax & vomiting & diarrhea gave APAP suppository-temp staying @ 101 ax;
FEVER OF 99-101; Tired; GROGGY; COULD NOT SLEEP; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers.  On MAR-2021, the subject experienced groggy. On MAR-2021, the subject experienced could not sleep. On MAR-2021, the subject experienced tired. On 16-MAR-2021, the subject experienced fever of 99-101. Body temperature (NR: not provided) 99-101 (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever of 99-101, groggy, could not sleep and tired was not reported. This report was non-serious.
Diarrhea started on 12/11/2009 and lasted for 4 days, itching in scalp/neck and skin rash around neck started on 12-13-09 and lasted through 12/14/09. No other symptoms. Denied change in hair care products.
Patient reported gastrointestinal paints and loose stool. Sore lump on collar bone area.
Headache, Diarrhea & NauseaVomiting  Narrative: ha day 1-3; diarrhea/vomiting 1 wk after vaccine - resolved
This spontaneous report was received from a pharmacist referring to a 16 year old female patient. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided. On an unknown date, the patient was vaccinated with 1 mL adult dose of VAQTA for prophylaxis (strength, route, lot # and expiration date were not reported). The patient reported no issues and was in a healthy weight and everything.
Covid-19. I tested positive for Covid 19 on July 14, 2022 I experienced congested sinuses, runny nose, cough, sore throat, fever, & extreme fatigue. I was taking DAYQUIL for my symptoms.
On 02/22/2001 the patient developed chicken pox with approximately 20 lesions and no other symptoms. On 02/27/2001 the patient had recovered.
Unknown vaccine clinic site. Patient was seen at Per internal reported event: 21 y.o.male with PMH significant for asthma who was admitted 5/15/2021 with CP.  Pt had Pfizer COVID vaccine #2 on 5/12.  He developed fever and myalgias on 5/13.  These had recovered by 5/14 - only complaint was sore arm and underarm swelling on the L.  By 5/15, pt had severe CP with dyspnea.  Taken to ED - noted to have elevated troponin and ST elevation on EKG.  Now s/p LHC today - coronaries clean.  Echo without wmas.  Cardiology suspects acute myocarditis.  No pericardial effusion to suggest pericarditis.
pt recv vax JAN96 & pt devel lower resp infect p/1st dose;no further details were provided;
4cm X 5cm area of erythema non indurated, non tender to palpation to Left deltoid vaccine site.
Placed in refridgerator on 29-OCT-2021, Vaccine expired on 13-OCT-2021 and Administered on 03-NOv-2021; 606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and POOR QUALITY PRODUCT ADMINISTERED (Placed in refridgerator on 29-OCT-2021, Vaccine expired on 13-OCT-2021 and Administered on 03-NOv-2021) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Placed in refridgerator on 29-OCT-2021, Vaccine expired on 13-OCT-2021 and Administered on 03-NOv-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) and POOR QUALITY PRODUCT ADMINISTERED (Placed in refridgerator on 29-OCT-2021, Vaccine expired on 13-OCT-2021 and Administered on 03-NOv-2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant information was reported. Date of placed in refrigerator was on 29-Oct-2021. Vaccine did not undergone any temperature excursion. No  adverse events were reported for patient. No treatment information was reported.
This spontaneous report as received from a physician refers to a patient of unknown demographics. No information regarding the patient's medical history, concomitant medications, concurrent conditions and drug reactions or allergies was provided. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX injection (dose, route of administration, lot number and expiration date were not reported). On an unknown date the patient developed redness with "tiny blisters", inflammation, tenderness to touch and pain at the injection site. The outcome of the events was unknown at the time of the report The relatedness between the events and ZOSTAVAX was not reported. Additional information has been requested.
On 4/26 with 7-9 MP erythematous lesions. A few are vesicular and 2 with crusting. No fever, slight runny nose. No other complaints except a dry rough patch of skin on scrotum. All resolved 5 days later.
high temperature of 99.6°F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (high temperature of 99.6°F) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced PYREXIA (high temperature of 99.6°F). At the time of the report, PYREXIA (high temperature of 99.6°F) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Body temperature: 99.6 degree f (High) 99.6 degree F.         Concomitant medications were not provided. Treatment information was not reported.
This spontaneous report as received from a consumer refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patient vaccinated with a dose of M-M-R II injection (strength, dose, frequency, route of administration, lot # and expiration date were not reported). On an unknown date the patient experienced unspecified reaction to the M-M-R II. The outcome of the adverse event was unknown. Additional information is not expected because the reporter did not provide contact details.
Minimal soreness at site; This is a spontaneous report from a contactable consumer (patient).  This 81-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL3248), via an unknown route of administration, on 20Jan2021 at 10:30 at a single dose on the left arrm for COVID-19 immunisation. No relevant medical history and concomitant medications were provided. After vaccination, the patient had minimal soreness at site. Second shot was scheduled on 04Mar2021. The outcome of the event was unknown.
Started to feel loopy around 3-4 hours post vaccine. Left arm (vaccination site) started to hurt, this lasted about 2-3 days. Napped and slept off the exhaustion. About 8 hours post vaccine, started to feel feverish, like the flu. Had fever, chills, bone aches throughout the 8 hour mark until about 24 hours post vaccine.   Period bleeding occurred on day 2 and has been atypical (usually no period), very dark and bright red, a bit each day.
Patient said she intially had pain from her thumb to her shoulder which she attributed to her bursitis. But a couple days passed and she noticed that her arm still hurt even without movement and after taking aspirin which usually helps her bursitis. She also says there is a red bump where the shot was given. It is the size of a silver dollar and is hard. The injection site is also hot and itchy.
pt recv vax 12SEP95 & 15FEB96 pt devel a varicella rash (over a dozen spots);nurse stated that the vax had been stored & administered according to the prescribing instructions;
2hr p/vax pt devel a fever of 104 as well as redness & soreness around the inj site;rxn subsided w/in 24hrs;
Patient is a 75 y.o. female patient of, MD with history of HTN, HL, CKD who presented with cough, nausea, vomiting, fevers, chills, found to have COVID 19.    Covid-19 Virus Infection Acute viral bronchitis  Date of onset of symptoms: 9/25/2022 Symptoms present on admission: nausea, vomiting, cough, fevers Date of covid positive test: 9/28/2022 Vaccination status: vaccinated Imaging: CXR on and on 10/1 admit negative  Oxygen requirements on admission: none  Current oxygen requirements: 95% on room air Medical therapy: decadron and doxycycline for bronchitis and wheezing  Consultants following: none  Anticipated special isolation end date: 10/5/2022 Supportive care Albuterol inhaler scheduled, mucinex, hycodan and tessalon prn for cough.  Acetaminophen and robaxin scheduled  Doxycycline and decadron added 10/1 for bronchitis and wheezing  Cough, wheezing significantly improved 10/2, saturating well on room air   Home O2 eval completed and no home needs identified   Chest pain Left side precordial pain, constant since early this morning. Not reproducible but worse intermittently with deep breaths.  Overall cough, resp status and oxygen levels improving, low suspicion for PE Suspect musculoskeletal etiology  CXR was negative on admit and on 10/1 I independently reviewed the EKG showing Twi in I, aVL, appear similar to previous, no acute ischemic ST-T changes Trops 28, flat no further cardiac testing warranted Recommend ibuprofen for chest pain relief   AKI on stage III CKD Cr 2.48 on admit, baseline is 1.5-2.0 Likely prerenal due to volume depletion Received 1 L bolus in ED, s/p continuous fluids, 500 cc bolus on 10/1  Cr improving,  1.93 9/28, stopped IVF  Stable around 1.7  stopped home ACEi and hydrochlorothiazide as BP stable and AKI on admit Encouraging oral intake, drinking Boost   Hypertension Home meds: coreg, norvasc Bps 100-130s systolic Resume norvasc, resume coreg at reduced doseHyperlipidemia Resume statin   Hypokalemia(Resolved) K was 3.0 on admit, replaced Resolved now
Patient received an expired dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine). On 06-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
11/14/22 late evening, patient started to notice the soreness and redness on site of administration. This was 48 hours after the vaccine. This same reaction happened with series dose #3. It has since progressed to about a 3 inch diameter and is becoming more painful. Pt tried using ibuprofen and benadryl. However, patient was still waking up from sleep due to the pain (while rolling onto that arm). Patient is on 2 lung cancer medications. Right now she is on a 1 month break currently. Same medications were taken last time this happened in 2021.
Immediate sensation of thickening of tongue, tingling on face. Later chills, fever, extreme exhaustion, swollen injection site with rash and peeling skin. Was ill for five days.
Headache, NauseaVomiting, arm soreness at injection site Narrative: N/A
Patient received booster dose of Pfizer vaccine on Friday 12/3/21 and had intermittent nose bleeds on following Sun 12/5 and Mon 12/6. Patient says episodes lasted 10-15 mins and when she called at 2:32pm on 12/6/21 the last episode had resolved 45 mins prior. Patient described these episode as one or two "clots" coming out of her nose each time. Gave patient the vsafe information to report to CDC and also suggested she follow up with her doctor if she has more nosebleeds or if they don't resolve right away. Patient said last time she had a nose bleed was several years prior and consisted of mild symptoms.
COVID-19 confirmed by positive COVID-19 test; COVID-19 confirmed by positive COVID-19 test; blocked nose and ears; drowsy, sleepy; This is a spontaneous report from a contactable consumer (patient). A 56-year-old male patient received his first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 15Mar2021 16:00 (lot number: EP7534), at the age of 55-years-old, at 1st dose, single in the left arm, and second dose on 05Apr2021 16:45 (lot number: EP7533), at the age of 55-years-old, via an unspecified route of administration at 2nd dose, single in the left arm; both for COVID-19 immunisation. The patient's medical history was not reported. The patient had no known allergies and had no COVID prior to vaccination. Concomitant medications included linum usitatissimum seed oil (FLAX), multivitamin, and plant steroids. The patient had no other vaccines in four weeks. On 31May2021 22:00, the patient experienced body ache, cough, blocked nose and ears, drowsy, sleepy, feeling tired, and exhausted with talking and working. On 02Jun2021, the patient was tested for COVID via COVID-19 nasal swab test, and result came out positive on 04Jun2021. Despite having the two doses of the vaccine 8 weeks prior, the patient still tested positive. The patient was vaccinated in a pharmacy or drug store. Treatments such as home quarantine and care for COVID were given to the patient. Outcome of all the events was recovering.
NOTIFIED BY PATIENTS WIFE AS FOLLOWS... "PHARMACIST, THIS IS (WIFE). I WANTED TO LET YOU KNOW (PATIENT) HAS TO GO TO THE DOCTOR FOR HIS SHOULDER PAIN AFTER RECEIVING A FLU SHOT GIVEN BY (PHARMACIST) THE OTHER DAY. YOU WERENT THERE SO HE GAVE IT. (PATIENT) EVEN SAID THAT HE THOUGHT SOMETHING WASNT RIGHT BECAUSE (PHARMACIST) HAD TO LEAN FORWARD TO PUT SHOT IN FURTHER. HE SAID IT WAS GIVEN AT THE VERY TOP OF HIS SHOULDER AND THE NEEDLE WOULDNT GO IN FURTHER. IVE EVEN TALKED TO OTHER PEOPLE WHO GOT THEIR SHOTS BY HIM AND THEY SAY THERE IS SOMETHING WRONG WITH HIS TECHNIQUE. EVERYONE KNOW HOW YOU GIVE SHOTS AND HE IS NOT DOING SOMTHING RIGHT. MAYBE YOU SHOULD TAKE A LOOK." --- ALSO AFTER TALKING TO WIFE MORE, PATIENT WENT TO PRIMARY DOCTOR FOR SHOT ADMINISTERED 10/22/2020. WAS REFERRED OUT TO BONE AND JOINT SPECIALIST AND WILL HAVE A SCAN OF SHOULDER. PER WIFE, DOCTOR STATES THERE HAS BEEN INJURY FROM ADMINISTRATION OF THE VACCINE. PATIENT ALSO BETWEEN DR AND SPECIALIST APPT WENT TO URGENT CARE AND RECEVIED A PRESCRIPTION AND STEROID INJECTION.
On 3/3/01, pt had vesicle type lesions noted on abdomen and buttocks. Fading. On 3/20/01, noted increased discomfort.
pea size lump that is sore in collar bone area, gone after a day or two. injection site sore for 24 hours Narrative:
A report was received from a physician concerning a 3 year old female patient with height of 78 centimeters and with weight of 11 kilograms. The patient's concurrent disease included congenital hypothyroidism. Concomitant medications included lidocaine, prilocaine, ipratropium bromide, levothyroxine and salbutamol. On 143-NOV-2015, the patient was administered  with nasal influenza virus. Report provided no information about the influenza vaccine manufacturer, brand, lot or route of administration. Patient had the flu vaccination. Soon after developed hives on the trunk and limbs. It was considered as an allergic reaction. At the time of reporting, the event of allergic reaction and hives was improving. According to the reporter the adverse events was considered to be serious with the serious criteria of important medical event.
Nausea with Vomiting X 1 Left side of tongue swelled but not enough to affect breathing
The patient is a 59 year old woman who received the H1N1 vaccine on 12/15.  She did not receive a seasonal flu shot.  Approximately two weeks after that, she developed lower extremity weakness and low back pain.  She saw her outpatient family physician who gave her a steroid injection which did help somewhat.  However, her symptoms progressed and what started a unilateral leg weakness became bilateral, so she was admitted to the hospital 1/4.  At no time did she have any evidence of infection: no fever, cough, diarrhea.  Her CXR, U/A, and head CT were normal.  Her WBC count is slightly elevated, but she did receive steroids.  Her lumbar spine MRI revealed mild disc disease.  Her CSF protein was slightly elevated.  She was initially admitted to ICU as a precaution, but did not require intubation.  She has been started on IVIG and is doing well.  Their working diagnosis is GUILLAIN-BARRE Syndrome (GBS), per MD.
By around 11pm the night of I started to feel the soreness in my arm which I was prepared for but when I woke up Sunday I was running a fever (and I still am), had fatigue in general but a muscle fatigue that impacted majority my body. It is very painful to move my left are even just a few inches making a simple task like  getting dressed painful. The lymph nodes around my left shoulder and neck are also tender.  I have never had even mild reactions to vaccines before so this is concerning to me.